HLA class I A2 tumor associated antigen peptides and vaccine compositions

US6602510B1 · kind B1 · utility

Assignee

• EPIMMUNE INC. · US

Inventors

• John D. Fikes · San Diego, US
• Alessandro Sette · Village of La Jolla, US
• John Sidney · Village of La Jolla, US
• Scott Southwood · Santee, US
• Esteban Celis · San Diego, US
• Elissa Keogh · San Diego, US
• Robert Chesnut · Cardiff-by-the-Sea, US

Key dates

• Filing date: Apr 5, 2000
• Grant date: Aug 5, 2003
• Expiry date: Apr 5, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K2239/31
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A composition or vaccine composition comprising eight isolated epitopes consisting of YLSGANLNV (SEQ. ID. NO: 1), IMIGVLVGV (SEQ. ID. NO: 2), KLBPVQLWV (SEQ. ID. NO: 3), SMPPPGTRV (SEQ. ID. NO: 4), KVAELVHFL (SEQ. ID. NO: 5), YLQLVFGIEV (SEQ. ID. NO: 6), RLLQETELV (SEQ. ID. NO: 7), and, VVLGVVFGI (SEQ. ID. NO: 8).